Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2019; 14(01): 262-265
DOI: 10.4103/ajns.AJNS_53_17
Case Report

Facial nerve paralysis occurring 4 days following stereotactic radiosurgery for a vestibular schwannoma

Kevin Chow
1   Department of Neurosurgery, Stanford University, California
,
Abdulrazag Ajlan
1   Department of Neurosurgery, Stanford University, California
2   Stanford Cancer Institute, Stanford University, California
,
Allen Ho
1   Department of Neurosurgery, Stanford University, California
,
Gordon Li
1   Department of Neurosurgery, Stanford University, California
2   Stanford Cancer Institute, Stanford University, California
,
Scott Soltys
2   Stanford Cancer Institute, Stanford University, California
3   Department of Radiation Oncology, Stanford University, California
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Stereotactic radiosurgery (SRS) is commonly used for the treatment of vestibular schwannomas given its high rate of tumor control and low rate of complications. Facial nerve palsy has been reported several months after treatment as a rare late complication of SRS. Here, we report a case of facial weakness occurring only 4 days after treatment and discuss potential etiology and management considerations.

Key-words:

Facial palsy - stereotactic radiosurgery - vestibular schwannoma

Financial support and sponsorship

Nil.




Publication History

Article published online:
09 September 2022

© 2019. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD. The newly diagnosed vestibular schwannoma: Radiosurgery, resection, or observation? Neurosurg Focus 2012;33:E8.
  • 2 Hansasuta A, Choi CY, Gibbs IC, Soltys SG, Tse VC, Lieberson RE, et al. Multisession stereotactic radiosurgery for vestibular schwannomas: Single-institution experience with 383 cases. Neurosurgery 2011;69:1200-9.
  • 3 Hasegawa T, Kida Y, Kato T, Iizuka H, Kuramitsu S, Yamamoto T, et al. Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: Evaluation of 440 patients more than 10 years after treatment with gamma knife surgery. J Neurosurg 2013;118:557-65.
  • 4 Lunsford LD, Niranjan A, Flickinger JC, Maitz A, Kondziolka D. Radiosurgery of vestibular schwannomas: Summary of experience in 829 cases. J Neurosurg 2005;Suppl 102:195-9.
  • 5 Sughrue ME, Yang I, Han SJ, Aranda D, Kane AJ, Amoils M, et al. Non-audiofacial morbidity after gamma knife surgery for vestibular schwannoma. Neurosurg Focus 2009;27:E4.
  • 6 Yang I, Sughrue ME, Han SJ, Fang S, Aranda D, Cheung SW, et al. Facial nerve preservation after vestibular schwannoma gamma knife radiosurgery. J Neurooncol 2009;93:41-8.
  • 7 Badakhshi H, Graf R, Böhmer D, Synowitz M, Wiener E, Budach V, et al. Results for local control and functional outcome after linac-based image-guided stereotactic radiosurgery in 190 patients with vestibular schwannoma. J Radiat Res 2014;55:288-92.
  • 8 Karam SD, Tai A, Strohl A, Steehler MK, Rashid A, Gagnon G, et al. Frameless fractionated stereotactic radiosurgery for vestibular schwannomas: A single-institution experience. Front Oncol 2013;3:121.
  • 9 Link MJ, Driscoll CL, Foote RL, Pollock BE. Radiation therapy and radiosurgery for vestibular schwannomas: Indications, techniques, and results. Otolaryngol Clin North Am 2012;45:353-66, viii-ix.
  • 10 Chou CH, Chen PJ, Lee PH, Cheng AL, Hsu HC, Cheng JC, et al. Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells. Clin Cancer Res 2007;13:851-7.
  • 11 Foote KD, Friedman WA, Buatti JM, Meeks SL, Bova FJ, Kubilis PS, et al. Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 2001;95:440-9.
  • 12 Collen C, Ampe B, Gevaert T, Moens M, Linthout N, De Ridder M, et al. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: A single-institution experience. Int J Radiat Oncol Biol Phys 2011;81:e503-9.
  • 13 Choy W, Spasic M, Pezeshkian P, Fong BM, Nagasawa DT, Trang A, et al. Outcomes of stereotactic radiosurgery and stereotactic radiotherapy for the treatment of vestibular schwannoma. Neurosurgery 2013;60 Suppl 1:120-5.
  • 14 Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010;76:193-200.
  • 15 Flickinger JC, Pollock BE, Kondziolka D, Phuong LK, Foote RL, Stafford SL, et al. Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study. Int J Radiat Oncol Biol Phys 2001;51:449-54.